These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3567490)

  • 21. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of erectile dysfunction using papaverine--2 1/2 years' experience].
    Schnyder von Wartensee M; Sieber A; Studer UE
    Schweiz Med Wochenschr; 1988 Jul; 118(30):1099-103. PubMed ID: 3175561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analyses of factors contributing to the erectile dysfunction with aging by nocturnal penile tumescence, penile blood pressure index and papaverine test].
    Aoki M; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1633-41. PubMed ID: 2287110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacocavernosography in the evaluation of erectile failure.
    Jantos C; Weidner W
    Urol Int; 1988; 43(4):225-30. PubMed ID: 3188291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamics of papaverine- and phentolamine-induced penile erection.
    Juenemann KP; Lue TF; Fournier GR; Tanagho EA
    J Urol; 1986 Jul; 136(1):158-61. PubMed ID: 3712604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The intracavernosal administration of papaverine in the diagnosis and treatment of sexual disorders in men].
    Gorpinchenko II; Khudaĭberdiev NA
    Vrach Delo; 1989 Oct; (10):102-5. PubMed ID: 2617964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
    Porst H
    Urologe A; 1988 Jan; 27(1):22-6. PubMed ID: 3284144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The actual incidence of papaverine-induced priapism in patients with erectile dysfunction following penile colour Doppler ultrasonography.
    Kilic M; Serefoglu EC; Ozdemir AT; Balbay MD
    Andrologia; 2010 Feb; 42(1):1-4. PubMed ID: 20078509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Priapism as a complication of the treatment of impotence by local injections of papaverine].
    Kaczmarek A
    Wiad Lek; 1990 Sep 1-15; 43(17-18):908-10. PubMed ID: 2278150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cavernosography using digital luminescence radiography (DLR) in the diagnosis of venous induced erectile function and of diseases of the corpus cavernosum].
    Papadopoulos I; Marks W; Christiansen GR; Weichert-Jacobsen K
    Urologe A; 1991 Jan; 30(1):67-9. PubMed ID: 2014588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A modified papaverine test and the use of venous constriction in erectile dysfunction.
    Lanigan D; Roobottom C; Choa RG
    Int J Impot Res; 1993 Sep; 5(3):119-22. PubMed ID: 8124429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence.
    Sarosdy MF; Hudnall CH; Erickson DR; Hardin TC; Novicki DE
    J Urol; 1989 Mar; 141(3):551-3. PubMed ID: 2645420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atropine role in the pharmacological erection test: study of 228 patients.
    Sogari PR; Telöken C; Souto CA
    J Urol; 1997 Nov; 158(5):1760-3. PubMed ID: 9334595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral terbutaline in the management of pharmacologically induced prolonged erection.
    Priyadarshi S
    Int J Impot Res; 2004 Oct; 16(5):424-6. PubMed ID: 14999218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury.
    Chancellor MB; Rivas DA; Panzer DE; Freedman MK; Staas WE
    Urology; 1994 Mar; 43(3):365-9. PubMed ID: 8134992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of transanal pelvic plexus stimulation on penile erection: clinical implications.
    Kayigil O; Agras K; Gurdal M; Serefoglu EC; Okulu E; Ucgul Y
    Int Urol Nephrol; 2007; 39(4):1195-201. PubMed ID: 17505909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential diagnosis in erectile impotence. Intracorporeal papaverine injection and RigiScan tumescence and rigidity monitoring.
    Giesbers AA; Kramer AE; Jonas U
    Acta Urol Belg; 1988; 56(2):192-201. PubMed ID: 3400525
    [No Abstract]   [Full Text] [Related]  

  • 38. The aging penis: erectile dysfunction.
    Monga M
    Geriatr Nephrol Urol; 1999; 9(1):27-37. PubMed ID: 10435225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intracavernous injection of prostaglandin E1 as a diagnostic test in erectile dysfunction].
    Marín Lafuente JC; Sańchez Moreno Horencia M; Puy Figuero Echeverría M; Llarena Ibarguren R; Pertusa Peña C
    Arch Esp Urol; 1990; 43(6):661-3. PubMed ID: 2092621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of effects following the intracorporeal injection of papaverine and prostaglandin E1.
    Chen JK; Hwang TI; Yang CR
    Br J Urol; 1992 Apr; 69(4):404-7. PubMed ID: 1581812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.